Supplementary materials and methods

Size: px
Start display at page:

Download "Supplementary materials and methods"

Transcription

1 Supplementary materials and methods Targeted resequencing RNA probes complementary in sequence to the coding exons (+ 2bp) of target genes were designed using e-array ( and manufactured as part of custom SureSelect kits (Agilent Santa Clara CA). A tiling frequency of 2x was selected during kit design and small target intervals were extended such that all intervals were targeted by at least 2 distinct probes. Paired end Illumina sequencing libraries were prepared for 444 cases and 3 controls using DNA extracted from venous blood (KBioscience Herts England). Libraries were subsequently enriched for target sequences using the custom SureSelect kits. Library preparation and target enrichment was performed as per the SureSelect Target Enrichment System for Illumina Paired-End Sequencing Library protocol version 2.3 protocol with the following modifications. ) Only µg of DNA was used in library preparations. 2) DNA fragmentation was performed either using a Covaris system (Covaris Woburn MA) as per the manufacturer's instructions enzymatically or through sonication. Where enzymatic fragmentation was performed 5.8 µl of DNA (63.3 ng/µl) was incubated with 2 µl NEBNext dsdna fragmentase (New England Biolabs Ipswich MA) in NEBNext fragmentase reaction 3 C for 2 min. 5 µl of.5 M EDTA was then used to stop the reaction. Where fragmentation was performed through sonication µl of DNA ( ng/µl) was subjected to 6 min of sonication (3 sec on 3 sec off) using a Bioruptor (Diagenode Liège Belgium) at low power. 3) Extended Illumina adapters including 6 bp indexes were used in place of standard adapters (Metabion Martinsried Germany). All indexes were at least an edit distance of 2 from one another. 4) Following adapter ligation libraries were subjected to electrophoresis through a 2% Low Range Ultra agarose gel (BioRad Hercules CA) stained with SYBR Green nucleic acid gel stain (Sigma Arklow Ireland) for 9 4 V. Fragments of 3 4 bp were manually

2 excised from gel using a Safe Imager 2. Blue Light Transilluminator (Invitrogen Carlsbad CA) for visualization. DNA was extracted from gel slices using QIAquick Gel Extraction Kits (Qiagen West Sussex UK) as per the manufacturer's instructions. 5) 5 cycles of PCR were performed instead of 4 prior to target enrichment and Phusion (New England Biolabs) was used for all PCR reactions. 6) Libraries labelled with distinct indexes were pooled prior to target enrichment such that the expected sequence coverage of target intervals would have a mean of ~ 3x per sample. 23 case libraries were resequenced by 8 bp paired-end resequencing on an Illumina Genome Analyzer II at TrinSeq Institute of Molecular Medicine Trinity College Dublin Ireland. The remainder of libraries were resequenced by bp single-end sequencing on a HiSeq 2 at GATC Biotech AG Konstanz Switzerland. Analysis of sequence data Sequencing reads were aligned using BWA to build GRCh37 of the human genome ( ). Alignments were annotated with sample of origin based on detected adapter indexes. SAMtools was used to sort and index alignment files. Picard was used to merge alignment files and remove PCR duplicates. The GATK was used to perform local indel realignment recalibrate base quality (BQ) scores determine per sample depth of coverage across target intervals call variants and assign sample genotypes. Base calls were only considered for depth of coverage analyses or variant calling when they were associated with BQ scores >= 2 and alignment mapping quality scores >=2. Variant annotation and quality control

3 The effects of variants at the protein level were predicted using Variant Effect Predictor version 2.7 ( and Ensembl 69 ( Predictions were based only on transcripts annotated as protein coding and included PolyPhen and SIFT pathogenicity classifications. Genotype frequencies within external control cohorts were imported from the March 22 release of the genomes project ( and the ESP65 release of the NHLBI exome sequencing project (Exome Variant Server NHLBI Exome Sequencing Project (ESP) Seattle WA (URL: [Accessed 22 Jul 8]). Variants were assigned a status of either pass or fail based on whether they met a series of quality control criteria. These criteria included a minimum variant quality score of 3 a genotype call rate >% and QD FS ReadPosRankSum and HaplotypeScore values within the range observed for the subset of variants noted also to have been reported by the genomes or NHLBI Exome Sequencing projects. Additionally novel case variants which were observed to occur only in cis with other novel case variants were interpreted as possible misalignments and assigned a status of fail. Variant quality score QD FS ReadPosRankSum and HaplotypeScore values were calculated using the GATK. Genotype calls associated with genotype quality scores <5 were reset to missing prior to variant quality control. Estimation of variant detection power For each target position per sample sequence coverage was used to calculate the expected total of resequenced chromosomes. The probability of including a mutated chromosome among this total was then calculated for a range of minor allele frequencies using R version 2.4. ( Both the sampling of patients from the Irish ALS population and the sampling of chromosomes during resequencing were assumed to follow binomial distributions.

4

5

6

7

8

9 Figure S: Variant detection power The horizontal axes denote position within the coding sequence of each target gene. The vertical axes denote the probability that a variant with an allele frequency of 5% (blue line).5% (yellow line) or.% (red line) among Irish ALS patients was sampled during resequencing. The coding sequence of a target gene refers to the union of all coding transcripts reported in Ensembl 69. Exon boundaries are demarcated by vertical dotted lines.

10 Table S: Target gene resequencing Gene Designation % Sequenced (>= X coverage) Mean Case Coverage ALS2 Mendelian ANG Mendelian ATXN2 Low penetrance/ tenative C9orf72 Mendelian CHMP2B Low penetrance/ tenative DCTN Low penetrance/ tenative DPP6 Low penetrance/ tenative ELP3 Low penetrance/ tenative FGGY Low penetrance/ tenative FIG4 Low penetrance/ tenative FUS Mendelian GRN Low penetrance/ tenative HFE Low penetrance/ tenative IFNK Low penetrance/ tenative ITPR2 Low penetrance/ tenative MAPT Low penetrance/ tenative MOB3B Low penetrance/ tenative NEFH Low penetrance/ tenative NIPA Low penetrance/ tenative OPTN Mendelian PARK7 Low penetrance/ tenative PON Low penetrance/ tenative

11 PON2 Low penetrance/ tenative PON3 Low penetrance/ tenative PRPH Low penetrance/ tenative Mendelian SIGMAR Low penetrance/ tenative SOD Mendelian SPG Low penetrance/ tenative TARDBP Mendelian UNC3A Low penetrance/ tenative VAPB Mendelian VCP Mendelian

12 Table S2: ALS gene variants Gene ALS2 Class Transcript DNA Amino.Acid SIFT *ENST ENST c.2g>a c.2g>a p.val368met p.val368met Poly Phen fals sals Irish European Global ALS2 splice region *ENST c.5c>g p.pro372arg ALS2 *ENST c.226c>g p.ala49gly ALS2 *ENST c.265t>c p.met422thr ALS2 *ENST c.283c>a p.thr428asn ALS2 *ENST c.627g>a p.asp543asn ALS2 splice region *ENST c.64g>a ALS2 *ENST c.228a>g ALS2 *ENST c.298a>g p.thr7ala ENST c.34a>g p.thr2ala ALS2 *ENST c.255c>t p.pro79ser ENST c.9c>t p.pro3ser ALS2 *ENST c.226c>t p.ala739val ENST c.52c>t p.ala5val ALS2 *ENST c.224c>t ENST c.77c>t ALS2 *ENST c.248a>g p.lys83arg ENST c.344a>g p.lys5arg ALS2 *ENST c.2466g>a ENST c.42g>a ALS2 *ENST c.2566a>g p.thr856ala ENST c.52a>g p.thr68ala ALS2 *ENST c.266a>c p.gln869pro ENST c.542a>c p.gln8pro ALS2 *ENST c.2796c>t ENST c.732c>t ALS2 *ENST c.28a>g p.ile94val ENST c.28a>g p.ile94val

13 ENST49632 ENST452 c.28a>g c.28a>g p.ile94val p.ile94val ALS2 *ENST c.2992c>a ENST c.928c>a ALS2 *ENST c.346c>g p.pro6ala ENST c.982c>g p.pro328ala ALS2 *ENST c.394c>t p.arg32cys ENST c.3c>t p.arg344cys ALS2 *ENST c.329c>g ENST c.65c>g ALS2 splice donor c.382+2t >G *ENST >G ENST c.8+2t ALS2 *ENST c.325t>g p.tyr84asp splice region ENST c.86t>g p.tyr396asp ALS2 *ENST c.337c>a p.his3asn ENST c.243c>a p.his45asn ALS2 *ENST c.374t>g ALS2 *ENST c.3863c>t p.pro288leu ALS2 *ENST c.3885g>a ALS2 *ENST c.45c>t ALS2 *ENST c.47g>a ALS2 *ENST c.49a>g p.ile373met ALS2 *ENST c.435c>a p.pro379thr ALS2 *ENST c.4382g>a p.arg46gln ALS2 *ENST c.464g>a ALS2 *ENST c.4957c>t p.arg653cys ANG *ENST3368 c.22a>t p.lys4ile ENST39799 c.22a>t p.lys4ile ANG *ENST3368 c.28a>g p.ile7val ENST39799 c.28a>g p.ile7val ANG *ENST3368 c.33t>g ENST39799 c.33t>g ANG *ENST3368 c.363a>t

14 ATXN2 ATXN2 ATXN2 ATXN2 ATXN2 ATXN2 splice region ENST39799 *ENST37767 ENST ENST554 ENST ENST47866 ENST38953 ENST *ENST37767 ENST ENST554 ENST ENST38953 *ENST37767 ENST ENST554 ENST38953 ENST38954 ENST ENST *ENST37767 ENST554 *ENST37767 ENST55844 ENST38954 ENST ENST38953 *ENST37767 ENST ENST55844 ENST ENST38954 ENST38953 ENST ENST55889 c.363a>t c.23g>a c.256g>a c.23g>a c.328g>a c.5g>a c.328g>a c.352g>a c.472a>g c.65a>g c.472a>g c.677a>g c.677a>g c.3a>g c.225a>g c.2939a>g c.22a>g c.65a>g c.233a>g c.57a>g c.39c>g c.39c>g c.3322c>t c.97c>t c.487c>t c.2527c>t c.2533c>t c.34c>t c.249c>t c.86c>t c.266c>t c.576c>t c.2622c>t c.44c>t c.65c>t p.asp375asn p.asp86asn p.asp375asn p.aspasn p.asp5asn p.aspasn p.asp8asn p.asn49ser p.asn22ser p.asn49ser p.asn226ser p.asn226ser p.tyr98cys p.leu7val p.leu7val p.pro8ser p.pro33ser p.pro63ser p.pro843ser p.pro845ser p.thr22met

15 ATXN2 ATXN2 *ENST37767 ENST55844 ENST38954 ENST ENST55889 ENST38953 ENST ENST *ENST37767 ENST38954 ENST55844 ENST ENST38953 ENST ENST *ENST37767 ENST554 c.349g>a c.266g>a c.656g>a c.494g>a c.45g>a c.272g>a c.257g>a c.2696g>a c.378g>a c.873g>a c.483g>a c.293g>a c.299g>a c.2787g>a c.7g>a c.743g>a c.743g>a p.ser64asn p.ser89asn p.ser29asn p.ser65asn p.val49ile p.ser9asn p.ser857asn p.ser899asn ATXN2 p.ser248asn p.ser248asn C9orf72 *ENST383 c.275g>a C9orf72 *ENST383 c.44c>t C9orf72 *ENST383 c.62a>g p.asn27ser ENST c.62a>g p.asn27ser ENST c.62a>g p.asn27ser C9orf72 *ENST383 c.87c>t CHMP2 *ENST26378 c.8a>g p.lys4glu B ENST49498 c.8a>g p.lys4glu CHMP2 *ENST26378 c.23g>t p.gln4his B ENST49498 c.23g>t p.gln4his CHMP2 *ENST26378 c.27c>t B ENST49498 c.27c>t CHMP2 *ENST26378 c.32t>c B ENST4766 c.89t>c *ENST26378 c.372a>c CHMP2 ENST4766 c.249a>c B ENST49498 c.282a>c DCTN *ENST36874 c.59c>t

16 DCTN DCTN DCTN DCTN ENST3943 ENST49438 ENST49567 ENST49868 ENST47639 ENST4924 *ENST36874 ENST49567 ENST47639 ENST49438 ENST4924 ENST3943 ENST49868 *ENST36874 ENST49438 ENST3943 ENST47639 ENST49567 ENST4924 ENST49868 *ENST36874 ENST49868 ENST49567 ENST4924 ENST3943 ENST49438 ENST47639 *ENST36874 ENST49868 c.38c>t c.657c>t c.999c>t c.8c>t c.657c>t c.948c>t c.6g>a c.g>a c.658g>a c.658g>a c.949g>a c.39g>a c.9g>a c.23c>a c.829c>a c.2c>a c.829c>a c.7c>a c.2c>a c.8c>a c.48g>a c.429g>a c.42g>a c.369g>a c.459g>a c.78g>a c.78g>a c.484g>a c.433g>a p.ala354thr p.ala334thr p.ala22thr p.ala22thr p.ala37thr p.ala347thr p.ala337thr p.arg4ser p.arg277ser p.arg44ser p.arg277ser p.arg39ser p.arg374ser p.arg394ser p.ala494thr p.ala477thr p.ala474thr p.ala457thr p.ala487thr p.ala36thr p.ala36thr p.arg495gln p.arg478gln

17 DCTN DCTN DCTN DCTN DCTN ENST49567 ENST3943 ENST4924 ENST47639 ENST49438 *ENST36874 ENST3943 ENST49868 ENST49567 ENST47639 ENST4924 ENST49438 *ENST36874 ENST49567 ENST4924 ENST47639 ENST49438 ENST49868 ENST3943 *ENST36874 ENST47639 ENST49438 ENST49868 ENST49567 ENST3943 ENST4924 *ENST36874 ENST49438 ENST47639 ENST3943 ENST4924 ENST49868 ENST49567 *ENST36874 ENST49438 c.424g>a c.463g>a c.373g>a c.82g>a c.82g>a c.29c>t c.998c>t c.968c>t c.959c>t c.67c>t c.98c>t c.67c>t c.229g>c c.249g>c c.298g>c c.87g>c c.87g>c c.258g>c c.288g>c c.2339t>c c.937t>c c.937t>c c.2288t>c c.2279t>c c.238t>c c.2228t>c c.2353c>t c.95c>t c.95c>t c.2332c>t c.2242c>t c.232c>t c.2293c>t c.2448a>g c.246a>g p.arg475gln p.arg488gln p.arg458gln p.arg36gln p.arg36gln p.glu737gln p.glu77gln p.glu7gln p.glu63gln p.glu63gln p.glu72gln p.glu73gln p.ile78thr p.ile646thr p.ile646thr p.ile763thr p.ile76thr p.ile773thr p.ile743thr p.arg785trp p.arg65trp p.arg65trp p.arg778trp p.arg748trp p.arg768trp p.arg765trp

18 DCTN DCTN DCTN DCTN splice acceptor ENST49868 ENST47639 ENST4924 ENST3943 ENST49567 *ENST36874 ENST49438 ENST47639 ENST4924 ENST3943 ENST49868 ENST49567 *ENST36874 ENST4924 ENST47639 ENST49567 ENST49868 ENST3943 ENST49438 *ENST36874 ENST49868 ENST49567 ENST3943 ENST49438 ENST47639 ENST4924 *ENST36874 ENST49567 c.2397a>g c.246a>g c.2337a>g c.2427a>g c.2388a>g c.255c>g c.249c>g c.249c>g c.244c>g c.253c>g c.25c>g c.249c>g c.2559c>t c.2448c>t c.257c>t c.2499c>t c.258c>t c.2538c>t c.257c>t c a>g c a>g c a>g c a>g c a>g c a>g c a>g c.2952c>g c.2892c>g p.leu85val p.leu77val p.leu77val p.leu84val p.leu844val p.leu834val p.leu83val

19 DCTN DCTN DCTN DCTN ENST49868 ENST4924 ENST49438 ENST47639 ENST3943 *ENST36874 ENST49438 ENST3943 ENST4924 ENST47639 ENST49868 ENST49567 *ENST36874 ENST49868 ENST49567 ENST49438 ENST47639 ENST3943 ENST4924 *ENST36874 ENST47639 ENST4924 ENST3943 ENST49438 ENST49868 ENST49567 *ENST36874 ENST49438 ENST47639 ENST49868 ENST3943 c.29c>g c.284c>g c.255c>g c.255c>g c.293c>g c.346g>a c.2744g>a c.325g>a c.335g>a c.2744g>a c.395g>a c.386g>a c.35c>t c.3435c>t c.3426c>t c.384c>t c.399c>t c.348c>t c.3375c>t c.3746c>t c.3344c>t c.362c>t c.3725c>t c.3329c>t c.368c>t c.367c>t c.3788t>g c.337t>g c.3386t>g c.3722t>g c.3767t>g p.arg49gln p.arg95gln p.arg42gln p.arg2gln p.arg95gln p.arg32gln p.arg29gln p.thr249ile p.thr5ile p.thr27ile p.thr242ile p.thrile p.thr227ile p.thr224ile p.val263gly p.val24gly p.val29gly

20 DCTN DCTN DCTN DCTN ENST49567 ENST4924 *ENST36874 ENST3943 ENST49567 ENST ENST479 *ENST36874 ENST47639 ENST49567 ENST4924 ENST49438 ENST3943 ENST49868 *ENST36874 ENST49868 ENST49567 ENST49438 ENST4924 ENST3943 ENST47639 *ENST36874 ENST3943 ENST49868 ENST49438 ENST4924 ENST49567 ENST47639 c.373t>g c.3662t>g c.42c>t c.42c>t c.42c>t c.63c>t c.54c>t c.586a>g c.84a>g c.526a>g c.475a>g c.84a>g c.565a>g c.535a>g c.597g>a c.546g>a c.537g>a c.95g>a c.486g>a c.576g>a c.95g>a c.73g>t c.692g>t c.662g>t c.3g>t c.62g>t c.653g>t c.3g>t p.val24gly p.val256gly p.val238gly p.val22gly p.ile96val p.ile62val p.ile76val p.ile59val p.ile62val p.ile89val p.ile79val p.arg238leu p.arg23leu p.arg22leu p.arg4leu p.arg2leu p.arg28leu p.arg4leu DCTN *ENST36874 c.8g>a

21 DCTN DPP6 DPP6 DPP6 DPP6 DPP6 ENST47639 ENST49567 ENST49438 ENST3943 ENST49868 ENST4924 *ENST36874 ENST ENST479 ENST49868 ENST43 ENST ENST3943 ENST42392 ENST44727 ENST4549 ENST49567 ENST4924 ENST *ENST37777 ENST46326 *ENST37777 ENST3327 ENST4439 ENST *ENST37777 ENST3327 ENST ENST4439 *ENST37777 ENST ENST3327 ENST4439 *ENST37777 ENST4439 c.399g>a c.74g>a c.399g>a c.78g>a c.75g>a c.69g>a c.82c>t c.3c>t c.94c>t c.3c>t c.3c>t c.3c>t c.82c>t c.3c>t c.3c>t c.3c>t c.82c>t c.3c>t c.3c>t c.4c>t c.4c>t c.458c>t c.272c>t c.266c>t c.37c>t c.459g>a c.273g>a c.38g>a c.267g>a c.66t>c c.295t>c c.43t>c c.424t>c c.7a>c c.59a>c p.arg28trp p.arg35trp p.arg32trp p.argtrp p.argtrp p.argtrp p.arg28trp p.argtrp p.argtrp p.argtrp p.arg28trp p.argtrp p.argtrp p.val487met p.val425met p.val38met p.val423met p.phe539ser p.phe432ser p.phe477ser p.phe475ser p.lys57gln p.lys57gln

22 DPP6 DPP6 DPP6 DPP6 DPP6 DPP6 DPP6 DPP6 splice acceptor ENST ENST3327 *ENST37777 ENST ENST3327 ENST4439 *ENST37777 ENST3327 ENST ENST4439 *ENST37777 ENST3327 ENST4439 ENST *ENST37777 ENST ENST4439 ENST3327 *ENST37777 ENST4439 ENST ENST3327 *ENST37777 ENST4439 ENST ENST3327 *ENST37777 ENST4439 ENST3327 ENST *ENST37777 ENST3327 c.39a>c c.525a>c c.896a>g c.575a>g c.7a>g c.74a>g c.9g>a c.725g>a c.59g>a c.79g>a c.227t>c c.94t>c c.935t>c c.86t>c c.225c>t c.884c>t c.23c>t c.29c>t c.2295a>g c.23a>g c.974a>g c.29a>g c.233c>t c.239c>t c.2c>t c.245c>t c.2373c>t c.28c>t c.287c>t c.252c>t c G>A p.lys464gln p.lys59gln

23 DPP6 DPP6 DPP6 DPP6 DPP6 ENST ENST4439 *ENST37777 ENST ENST3327 ENST4439 *ENST37777 ENST3327 ENST4439 ENST *ENST37777 ENST4439 ENST3327 *ENST37777 ENST4439 ENST3327 *ENST37777 ENST3327 ENST4439 c.292- G>A c.257- G>A c.286- G>A c.2427g>a c.26g>a c.224g>a c.2235g>a c.256t>c c.2375t>c c.2369t>c c.224t>c c.657c>t c.465c>t c.47c>t c.666c>t c.474c>t c.48c>t c.723a>g c.537a>g c.53a>g p.leu854pro p.leu792pro p.leu79pro p.leu747pro DPP6 * ENST46326 c.785c>t p.ser262leu *ENST37777 c.879t>c DPP6 ENST4439 c.687t>c ENST3327 c.693t>c ENST c.558t>c DPP6 DPP6 splice region *ENST37777 ENST3327 ENST ENST4439 *ENST37777 ENST3327 ENST c.883g>a c.697g>a c.562g>a c.69g>a c.945c>t c.759c>t c.624c>t p.glu295lys p.glu233lys p.glu88lys p.glu23lys

24 ENST4439 c.753c>t *ENST37777 c.948c>t DPP6 ENST4439 c.756c>t ENST c.627c>t ENST3327 c.762c>t DPP6 * ENST46326 c.982t>g p.cys328gly *ENST c.68g>a ELP3 ENST5243 c.852g>a ENST38353 c.792g>a ENST c.7g>a ENST525 c.26g>a ENST5428 c.68g>a ELP3 ELP3 ELP3 *ENST ENST57975 ENST ENST38353 ENST5243 ENST525 ENST ENST5428 *ENST ENST525 ENST5257 ENST52424 ENST5299 ENST52288 ENST5227 *ENST ENST38353 ENST525 ENST5428 ENST5243 ENST ENST c.38g>a c.97g>a c.5g>a c.42g>a c.2g>a c.276g>a c.96g>a c.93g>a c.39g>a c.97g>a c.97g>a c.39g>a c.97g>a c.97g>a c.97g>a c.459c>t c.83c>t c.47c>t c.72c>t c.243c>t c.256c>t c.2c>t p.glu44lys p.glu33lys p.glu39lys p.glu348lys p.glu368lys p.glu426lys p.glu32lys p.glu3lys p.ala47thr p.ala33thr p.ala33thr p.ala47thr p.ala33thr p.ala33thr p.ala33thr p.arg487trp p.arg395trp p.arg473trp p.arg358trp p.arg45trp p.arg86trp p.arg368trp ELP3 *ENST c.26g>t p.arg69leu

25 ELP3 ELP3 FGGY FGGY FGGY initiator codon splice region splice donor ENST52288 ENST5257 ENST525 ENST5299 ENST52424 ENST5227 *ENST ENST5299 ENST5243 ENST38353 ENST52288 ENST5428 ENST5257 ENST52424 ENST525 ENST5227 ENST c.64g>t c.64g>t c.64g>t c.64g>t c.26g>t c.64g>t c.326g>a c.284g>a c.g>a c.5g>a c.284g>a c.3g>a c.284g>a c.326g>a c.284g>a c.284g>a c.33g>a p.arg55leu p.arg55leu p.arg55leu p.arg55leu p.arg69leu p.arg55leu p.cys9tyr p.cys95tyr p.cys37tyr p.cys7tyr p.cys95tyr p.met? p.cys95tyr p.cys9tyr p.cys95tyr p.cys95tyr p.metile * ENST c.366g>a *ENST3728 ENST3372 ENST372 ENST3722 *ENST3728 ENST3372 ENST3722 ENST372 *ENST3728 ENST ENST43489 c.53a>g c.53a>g c.56a>g c.789a>g c.22+2t >C c.22+2t >C c.957+2t> C c.324+2t> C c.29t>g c.29t>g c.29t>g p.asn43lys p.asn43lys p.asn43lys

26 FGGY FGGY FGGY FGGY FGGY FGGY FGGY FGGY feature elongation frameshift ENST3372 ENST3722 *ENST3728 ENST3372 ENST3722 ENST372 *ENST3728 ENST372 ENST3372 ENST3722 *ENST3728 ENST43489 ENST3372 ENST3722 *ENST3728 ENST3372 ENST43489 *ENST3728 ENST3372 ENST3722 ENST ENST43489 *ENST3728 ENST3722 ENST43489 ENST3372 *ENST3728 ENST43489 ENST3722 ENST3372 *ENST3728 ENST3372 c.29t>g c.29t>g c.56c>t c.488c>t c.224c>t c.59c>t c.76g>a c.747g>a c.644g>a c.38g>a c.88g>c c.88g>c c.88g>c c.88g>c c.4_42i nsg c.4_42i nsg c.4_42i nsg c.49g>a c.49g>a c.49g>a c.49g>a c.49g>a c.56g>a c.252g>a c.56g>a c.56g>a c.56g>c c.56g>c c.252g>c c.56g>c c.64g>a c.64g>a p.asn43lys p.asn43lys p.met572ile p.met249ile p.met548ile p.met46ile p.cys63ser p.cys63ser p.cys63ser p.cys63ser p.val4glyf sx25 p.val4glyf sx25 p.val4glyf sx25 p.val7ile p.val7ile p.val7ile p.val7ile p.val7ile p.ser25asn p.ser25asn

27 FGGY FGGY FGGY FGGY FGGY FGGY FIG4 FIG4 FIG4 FIG4 FIG4 FIG4 FIG4 splice region splice region ENST3722 c.35g>a p.ser7asn *ENST3728 c.622a>g p.lys28glu ENST3372 c.622a>g p.lys28glu ENST3722 c.358a>g p.lys2glu *ENST3728 ENST3722 ENST3372 *ENST3728 ENST3722 ENST3372 *ENST3728 ENST3372 ENST3722 *ENST3728 ENST3722 ENST3372 ENST372 *ENST3728 ENST3372 ENST3722 ENST372 *ENST2324 ENST44478 *ENST2324 ENST45425 *ENST2324 ENST44478 *ENST2324 ENST44478 *ENST2324 ENST44478 *ENST2324 ENST44478 *ENST2324 ENST44478 c.63t>a c.366t>a c.63t>a c.8g>t c.536g>t c.8g>t c.857c>t c.857c>t c.593c>t c.93g>t c.639g>t c.93g>t c.6g>t c.979a>c c.979a>c c.75a>c c.82a>c c.9a>t c.259a>t c.22t>c c.59t>c c.35g>c c.474g>c c.426c>t c.595c>t c.525c>t c.694c>t c.527g>a c.696g>a c.793t>a c.962t>a p.gly267val p.gly79val p.gly267val p.thr286met p.thr286met p.thr98met p.asn327his p.asn327his p.asn239his p.asn28his p.met364leu p.met87leu p.ile4thr p.ile2thr p.arg476cys p.arg99cys p.phe598tyr p.phe32tyr

28 FIG4 FIG4 FIG4 FIG4 FUS FUS FUS FUS FUS FUS splice acceptor inframe deletion ENST4598 c.2t>a p.phe7tyr *ENST2324 c.96t>c p.val654ala ENST44478 c.3t>c p.val377ala *ENST2324 c.22g>a p.glu734lys ENST4995 c.2g>a p.glu4lys ENST44478 c.369g>a p.glu457lys *ENST2324 c.2559g>a ENST44478 c.64g>a *ENST2324 ENST45425 ENST44478 ENST36894 *ENST2548 ENST38244 ENST *ENST2548 ENST ENST38244 *ENST2548 ENST38244 ENST *ENST2548 ENST38244 ENST *ENST2548 ENST ENST38244 *ENST2548 ENST38244 ENST c.447-2a>t c.384-2a>t c.9-2a>t c.26-2a>t c.8c>t c.77c>t c.83c>t c.24_2 6delAGT c.27_2 9delAGT c.2_2 3delAGT c.32c>t c.32c>t c.32c>t c.47c>a c.47c>a c.47c>a c.53c>t c.53c>t c.53c>t c.545t>g c.542t>g c.548t>g p.ser42del p.ser43del p.ser4del

29 FUS FUS FUS FUS FUS FUS FUS FUS FUS FUS FUS inframe deletion *ENST2548 ENST ENST38244 *ENST2548 ENST ENST38244 *ENST2548 ENST ENST38244 *ENST2548 ENST38244 ENST *ENST2548 ENST ENST38244 *ENST2548 ENST ENST38244 *ENST2548 ENST ENST38244 *ENST2548 ENST38244 ENST *ENST2548 ENST38244 ENST *ENST2548 ENST38244 ENST *ENST2548 ENST38244 c.566g>a c.569g>a c.563g>a c.574c>t c.577c>t c.57c>t c.65_67 delttc c.65_67 delttc c.65_67 delttc c.23g>c c.228g>c c.23g>c c.232a>c c.232a>c c.229a>c c.234t>c c.234t>c c.23t>c c.29c>t c.29c>t c.288c>t c.339c>t c.336c>t c.339c>t c.422a>c c.49a>c c.422a>c c.423a>t c.42a>t c.423a>t c.74a>g c.74a>g p.pro525leu p.pro526leu p.pro524leu p.ser56del p.ser56del p.ser56del p.thr78pro p.thr78pro p.thr77pro p.gln4pro p.gln4pro p.gln4pro p.gln4his p.gln4his p.gln4his p.tyr25cys p.tyr25cys

30 GRN GRN GRN GRN GRN GRN GRN GRN ENST c.74a>g p.tyr25cys *ENST53867 c.297c>t p.arg433trp ENST c.738c>t p.arg247trp ENST c.826c>t p.arg276trp *ENST53867 c.695c>t ENST c.224c>t *ENST53867 c.762g>t p.ala588ser ENST c.29g>t p.ala43ser *ENST53867 ENST ENST5974 ENST58758 ENST59367 ENST58843 ENST ENST *ENST53867 ENST ENST *ENST53867 ENST ENST *ENST53867 ENST ENST *ENST53867 ENST58552 ENST ENST59367 ENST ENST58758 ENST5879 ENST5974 ENST58843 ENST c.384t>c c.384t>c c.384t>c c.384t>c c.384t>c c.384t>c c.384t>c c.426t>c c.693c>g c.34c>g c.495c>g c.75c>a c.46c>a c.57c>a c.97g>a c.499g>a c.4g>a c.99c>t c.99c>t c.99c>t c.99c>t c.99c>t c.99c>t c.99c>t c.99c>t c.99c>t c.99c>t p.cys23trp p.cys45trp p.cys65trp p.ala324thr p.ala67thr p.ala38thr

31 HFE HFE HFE HFE HFE ENST ENST *ENST35768 ENST37896 ENST46397 ENST39234 ENST4749 ENST *ENST35768 ENST39234 ENST ENST37896 ENST46397 ENST4749 ENST39722 *ENST35768 ENST39722 ENST39234 ENST46397 ENST4749 ENST37896 ENST *ENST35768 ENST35347 ENST39234 ENST48899 ENST ENST ENST46397 ENST4749 ENST ENST37896 ENST39722 *ENST35768 ENST37896 c.99c>t c.99c>t c.38g>a c.38g>a c.38g>a c.38g>a c.38g>a c.38g>a c.57g>a c.57g>a c.57g>a c.57g>a c.57g>a c.57g>a c.88g>a c.87c>g c.8c>g c.87c>g c.87c>g c.87c>g c.87c>g c.87c>g c.8g>c c.8g>c c.8g>c c.8g>c c.8g>c c.8g>c c.8g>c c.8g>c c.8g>c c.8g>c c.8g>c c.93a>t c.93a>t p.val53met p.val53met p.val53met p.val53met p.val53met p.val53met p.val3met p.his63asp p.his4asp p.his63asp p.his63asp p.his63asp p.his63asp p.his63asp p.arg6ser p.arg6ser p.arg6ser p.arg6ser p.arg6ser p.arg6ser p.arg6ser p.arg6ser p.arg6ser p.arg6ser p.arg6ser p.ser65cys p.ser65cys

32 HFE HFE HFE HFE ENST4749 ENST ENST39722 ENST39234 ENST46397 *ENST35768 ENST48899 ENST ENST39234 ENST46397 ENST4749 ENST39722 *ENST35768 ENST ENST39234 ENST35347 ENST46397 ENST4749 ENST48899 ENST ENST37896 ENST39722 ENST *ENST35768 ENST ENST4749 ENST37896 ENST39234 ENST39722 ENST35347 ENST48899 ENST ENST46397 *ENST35768 ENST37896 c.93a>t c.93a>t c.24a>t c.93a>t c.93a>t c.52g>c c.238g>c c.238g>c c.52g>c c.52g>c c.52g>c c.433g>c c.5c>t c.5c>t c.5c>t c.5c>t c.5c>t c.5c>t c.5c>t c.5c>t c.5c>t c.5c>t c.5c>t c.67c>t c.352c>t c.66c>t c.394c>t c.67c>t c.6c>t c.3c>t c.364c>t c.46c>t c.628c>t c.68g>a c.68g>a p.ser65cys p.ser65cys p.ser42cys p.ser65cys p.ser65cys p.glu68gln p.glu8gln p.glu8gln p.glu68gln p.glu68gln p.glu68gln p.glu45gln p.thr7ile p.thr7ile p.thr7ile p.thr7ile p.thr7ile p.thr7ile p.thr7ile p.thr7ile p.thr7ile p.thr7ile p.thr7ile p.arg224trp p.arg8trp p.arg22trp p.arg32trp p.arg224trp p.arg2trp p.arg44trp p.arg22trp p.arg36trp p.arg2trp p.arg23his p.arg23his

33 HFE HFE HFE ENST39234 ENST4749 ENST ENST39722 ENST ENST35347 ENST48899 ENST ENST46397 *ENST35768 ENST35347 ENST ENST39234 ENST46397 ENST48899 ENST ENST39722 ENST37896 ENST4749 *ENST35768 ENST ENST48899 ENST37896 ENST39234 ENST4749 ENST39722 ENST46397 ENST35347 ENST *ENST35768 ENST48899 ENST37896 ENST4749 ENST39234 ENST c.68g>a c.68g>a c.68g>a c.68g>a c.68g>a c.68g>a c.68g>a c.68g>a c.68g>a c.766g>a c.226g>a c.52g>a c.766g>a c.724g>a c.46g>a c.448g>a c.697g>a c.49g>a c.757g>a c.829g>a c.565g>a c.523g>a c.553g>a c.829g>a c.82g>a c.76g>a c.787g>a c.289g>a c.5g>a c.845g>a c.539g>a c.569g>a c.836g>a c.845g>a c.58g>a p.arg23his p.arg23his p.arg23his p.arg23his p.arg23his p.arg23his p.arg23his p.arg23his p.arg23his p.val256ile p.val76ile p.val68ile p.val256ile p.val242ile p.val54ile p.val5ile p.val233ile p.val64ile p.val253ile p.glu277lys p.glu89lys p.glu75lys p.glu85lys p.glu277lys p.glu274lys p.glu254lys p.glu263lys p.glu97lys p.glu7lys p.cys282tyr p.cys8tyr p.cys9tyr p.cys279tyr p.cys282tyr p.cys94tyr

34 ENST ENST46397 ENST35347 ENST39722 c.527g>a c.83g>a c.35g>a c.776g>a p.cys76tyr p.cys268tyr p.cys2tyr p.cys259tyr IFNK *ENST c.263a>g p.tyr88cys IFNK *ENST c.279g>a IFNK *ENST c.282c>t IFNK feature elongation frameshift *ENST c.3_3ins TGTT p.trp3phefs X IFNK *ENST c.397a>g p.lys33glu IFNK stop gained *ENST c.43g>t p.glu5x IFNK *ENST c.486g>c ITPR2 stop gained *ENST3834 c.38c>t p.arg44x ITPR2 *ENST3834 c.358c>t p.ala453val ITPR2 *ENST3834 c.674c>t ITPR2 *ENST3834 c.857c>t ITPR2 *ENST3834 c.95a>g ITPR2 *ENST3834 c.26a>c ITPR2 *ENST3834 c.28t>c p.met673thr ITPR2 *ENST3834 c.255a>g ITPR2 *ENST3834 c.2262a>c ITPR2 *ENST3834 c.2358c>t ITPR2 *ENST3834 c.2694c>t ITPR2 *ENST3834 c.2854c>t p.pro952ser ITPR2 *ENST3834 c.2883c>t ITPR2 *ENST3834 c.37g>a ITPR2 stop gained *ENST3834 c.3358c>t p.arg2x ITPR2 *ENST3834 c.3369a>g ITPR2 *ENST3834 c.3485t>g p.val62gly ITPR2 *ENST3834 c.3539g>a p.arg8gln ITPR2 *ENST3834 c.364g>a p.arg25gln ITPR2 *ENST3834 c.3635c>t p.ala22val

35 ITPR2 *ENST3834 c.3824g>a p.arg275gln ITPR2 *ENST3834 c.423c>t ITPR2 *ENST3834 c.425c>t ITPR2 *ENST3834 c.4239c>t ITPR2 *ENST3834 c.435a>g ITPR2 *ENST3834 c.447a>g ITPR2 *ENST3834 c.4482c>t ITPR2 splice region *ENST3834 c.4962g>a ITPR2 *ENST3834 c.58t>c ITPR2 *ENST3834 c.575g>a ITPR2 *ENST3834 c.533c>t ITPR2 *ENST3834 c.5569c>t ITPR2 *ENST3834 c.57g>c ITPR2 *ENST3834 c.622g>a p.ala28thr ITPR2 *ENST3834 c.6346g>c p.ala26pro ITPR2 *ENST3834 c.6389c>t p.ser23leu ITPR2 *ENST3834 c.639g>a ITPR2 *ENST3834 c.6529a>c p.lys277gln ITPR2 *ENST3834 c.6833t>c p.leu2278pro ITPR2 *ENST3834 c.6966t>c ITPR2 splice region *ENST3834 c.74t>g ITPR2 *ENST3834 c.758g>a ITPR2 *ENST3834 c.765a>g ITPR2 *ENST3834 c.798g>a ITPR2 *ENST3834 c.82g>a p.ala2668thr *ENST34429 c.8c>t p.arg37trp MAPT ENST2624 c.8c>t p.arg37trp 2 ENST4563 c.8c>t p.arg37trp ENST57987 c.8c>t p.arg37trp MAPT *ENST34429 ENST4563 c.28c>t c.28c>t p.ser427phe p.ser427phe

36 MAPT MAPT MAPT MAPT MAPT ENST57987 ENST2624 *ENST34429 ENST4563 ENST2624 ENST57987 *ENST34429 ENST57987 ENST4563 ENST2624 *ENST34429 ENST57987 ENST4563 ENST2624 *ENST34429 ENST4563 ENST35559 ENST34799 ENST57987 ENST42682 ENST ENST57658 ENST438 ENST44636 ENST ENST ENST ENST2624 *ENST34429 ENST57658 ENST ENST ENST42682 ENST c.28c>t c.28c>t c.36c>a c.36c>a c.36c>a c.36c>a c.32t>c c.32t>c c.32t>c c.32t>c c.339t>c c.339t>c c.339t>c c.339t>c c.45g>a c.45g>a c.454g>a c.367g>a c.45g>a c.367g>a c.454g>a c.247g>a c.454g>a c.28g>a c.72g>a c.454g>a c.28g>a c.45g>a c.479g>a c.32g>a c.246g>a c.528g>a c.44g>a c.354g>a p.ser427phe p.ser427phe p.pro436thr p.pro436thr p.pro436thr p.pro436thr p.tyr44his p.tyr44his p.tyr44his p.tyr44his p.ser447pro p.ser447pro p.ser447pro p.ser447pro p.ala469thr p.ala469thr p.ala52thr p.ala23thr p.ala469thr p.ala23thr p.ala52thr p.ala83thr p.ala52thr p.ala94thr p.ala58thr p.ala52thr p.ala94thr p.ala469thr

37 MAPT MAPT MAPT ENST ENST2624 ENST438 ENST44636 ENST35559 ENST57987 ENST4563 ENST34799 *ENST34429 ENST4563 *ENST34429 ENST57987 ENST35559 ENST34799 ENST4563 ENST ENST438 ENST44636 ENST57658 ENST2624 ENST ENST ENST42682 ENST *ENST34429 ENST ENST42682 ENST57987 ENST ENST4563 ENST35559 ENST2624 ENST44636 ENST438 ENST34799 c.528g>a c.479g>a c.528g>a c.354g>a c.528g>a c.479g>a c.479g>a c.44g>a c.52t>c c.52t>c c.686a>g c.632a>g c.68a>g c.594a>g c.686a>g c.57a>g c.68a>g c.57a>g c.474a>g c.632a>g c.68a>g c.399a>g c.594a>g c.68a>g c.72g>a c.433g>a c.628g>a c.666g>a c.54g>a c.72g>a c.75g>a c.666g>a c.54g>a c.75g>a c.628g>a p.ala574thr p.ala45thr p.ala2thr p.ala556thr p.ala8thr p.ala574thr p.ala239thr p.ala556thr p.ala8thr p.ala239thr p.ala2thr

38 MAPT MAPT MAPT ENST ENST57658 ENST *ENST34429 ENST35559 ENST44636 ENST ENST34799 ENST ENST ENST2624 ENST57658 ENST438 ENST ENST57987 ENST42682 ENST4563 *ENST34429 ENST44636 ENST ENST35559 ENST57987 ENST ENST42682 ENST ENST34799 ENST57658 ENST ENST438 ENST4563 ENST2624 *ENST34429 ENST44636 ENST57987 ENST42682 c.75g>a c.58g>a c.75g>a c.77t>c c.765t>c c.59t>c c.765t>c c.678t>c c.59t>c c.765t>c c.76t>c c.558t>c c.765t>c c.483t>c c.76t>c c.678t>c c.77t>c c.85g>a c.636g>a c.8g>a c.8g>a c.76g>a c.636g>a c.723g>a c.528g>a c.723g>a c.63g>a c.8g>a c.8g>a c.85g>a c.76g>a c.278g>a c.999g>a c.224g>a c.86g>a p.ala239thr p.ala7thr p.ala239thr

39 MAPT MAPT MAPT MAPT MAPT ENST ENST ENST57658 ENST4563 ENST34799 ENST35559 ENST438 ENST ENST2624 ENST *ENST34429 ENST438 ENST2624 ENST57987 ENST ENST ENST35559 ENST4563 *ENST34429 ENST4563 ENST57987 ENST2624 *ENST34429 ENST2624 ENST4563 ENST57987 *ENST34429 ENST4563 ENST2624 ENST57987 *ENST34429 ENST2624 ENST4563 ENST57987 c.96g>a c.8g>a c.873g>a c.278g>a c.86g>a c.73g>a c.8g>a c.798g>a c.224g>a c.73g>a c.284c>t c.284c>t c.284c>t c.284c>t c.284c>t c.284c>t c.284c>t c.284c>t c.65c>t c.65c>t c.65c>t c.65c>t c.67t>g c.67t>g c.67t>g c.67t>g c.689a>g c.689a>g c.689a>g c.689a>g c.698c>t c.698c>t c.698c>t c.698c>t p.thr95met p.thr95met p.thr95met p.thr95met p.thr95met p.thr95met p.thr95met p.thr95met p.pro22leu p.pro22leu p.pro22leu p.pro22leu p.val224gly p.val224gly p.val224gly p.val224gly p.gln23arg p.gln23arg p.gln23arg p.gln23arg p.pro233leu p.pro233leu p.pro233leu p.pro233leu MAPT stop gained * ENST57658 c.7a>t p.lys3x

40 MAPT MAPT MAPT *ENST34429 ENST57987 ENST2624 ENST4563 *ENST34429 ENST2624 ENST57987 ENST4563 *ENST34429 ENST4563 ENST2624 ENST57987 c.853g>a c.853g>a c.853g>a c.853g>a c.855c>t c.855c>t c.855c>t c.855c>t c.866t>c c.866t>c c.866t>c c.866t>c p.asp285asn p.asp285asn p.asp285asn p.asp285asn p.val289ala p.val289ala p.val289ala p.val289ala MOB3B *ENST c.44c>t MOB3B *ENST c.65g>a MOB3B *ENST c.98g>a p.arg33gln NEFH *ENST3624 c.54c>a p.arg352ser NEFH *ENST3624 c.5g>a p.ala369thr NEFH *ENST3624 c.2c>t NEFH *ENST3624 c.387g>a p.glu463lys NEFH *ENST3624 c.58c>t p.pro527leu NEFH *ENST3624 c.74c>t NEFH *ENST3624 c.844c>t p.pro65leu NEFH *ENST3624 c.933g>a p.glu645lys NEFH feature elongation frameshift *ENST3624 c.935_9 36insG p.ala646glyf sx NEFH *ENST3624 c.935a>g NEFH *ENST3624 c.938a>c NEFH *ENST3624 c.965a>t NEFH inframe deletion *ENST3624 c.97_9 75delAGG AAG p.glu658_glu 659del NEFH *ENST3624 c.973a>c p.glu658ala NEFH *ENST3624 c.974a>c p.glu658asp NEFH *ENST3624 c.975g>a p.glu659lys

41 NEFH *ENST3624 c.989t>a NEFH *ENST3624 c.282c>t NEFH *ENST3624 c.2232t>c NEFH inframe c.2368_23 *ENST3624 deletion 7delAAG p.lys79del NEFH *ENST3624 c.244a>c p.glu85ala NEFH *ENST3624 c.2646c>t NEFH *ENST3624 c.274g>a p.val94met NEFH *ENST3624 c.2757c>t NEFH *ENST3624 c.2784a>g NEFH *ENST3624 c.2977a>g p.lys993glu NIPA NIPA OPTN OPTN OPTN *ENST ENST43792 ENST5683 *ENST ENST43792 ENST5683 *ENST26336 ENST ENST ENST ENST ENST *ENST26336 ENST ENST ENST ENST ENST *ENST26336 ENST ENST ENST ENST ENST c.233t>g c.8t>g c.8t>g c.44a>g c.26a>g c.26a>g c.2g>a c.2g>a c.2g>a c.2g>a c.2g>a c.2g>a c.92c>g c.74c>g c.92c>g c.74c>g c.92c>g c.92c>g c.23g>a c.23g>a c.23g>a c.23g>a c.23g>a c.23g>a p.val78gly p.val3gly p.val3gly p.gln398glu p.gln392glu p.gln398glu p.gln392glu p.gln398glu p.gln398glu

42 OPTN OPTN OPTN OPTN OPTN *ENST26336 ENST ENST ENST ENST ENST *ENST26336 ENST ENST ENST ENST438 ENST ENST *ENST26336 ENST ENST438 ENST ENST ENST ENST *ENST26336 ENST ENST ENST438 ENST ENST ENST *ENST26336 ENST ENST ENST438 ENST ENST ENST c.569g>a c.569g>a c.55g>a c.569g>a c.55g>a c.569g>a c.87c>a c.87c>a c.87c>a c.87c>a c.6c>a c.87c>a c.87c>a c.23g>a c.23g>a c.42g>a c.23g>a c.23g>a c.23g>a c.23g>a c.287g>a c.287g>a c.287g>a c.6g>a c.287g>a c.287g>a c.287g>a c.293t>a c.293t>a c.293t>a c.22t>a c.293t>a c.293t>a c.293t>a p.gln63lys p.gln63lys p.gln63lys p.gln63lys p.gln6lys p.gln63lys p.gln63lys p.arg96his p.arg96his p.arg96his p.arg39his p.arg96his p.arg96his p.arg96his p.met98lys p.met98lys p.met98lys p.met4lys p.met98lys p.met98lys p.met98lys OPTN *ENST26336 c.489a>g

43 OPTN OPTN PARK7 PARK7 PARK7 ENST ENST ENST438 ENST ENST ENST *ENST26336 ENST ENST438 ENST ENST ENST ENST *ENST26336 ENST ENST ENST ENST ENST *ENST ENST ENST37749 ENST ENST ENST *ENST ENST ENST ENST ENST ENST ENST37749 *ENST ENST ENST c.489a>g c.489a>g c.38a>g c.489a>g c.489a>g c.489a>g c.53c>t c.53c>t c.342c>t c.53c>t c.53c>t c.53c>t c.53c>t c.964a>g c.964a>g c.964a>g c.964a>g c.946a>g c.946a>g c.234c>t c.7c>t c.234c>t c.234c>t c.234c>t c.234c>t c.293g>a c.293g>a c.233g>a c.76g>a c.293g>a c.293g>a c.293g>a c.49a>c c.49a>c c.49a>c p.lys322glu p.lys322glu p.lys322glu p.lys322glu p.lys36glu p.lys36glu p.arg98gln p.arg98gln p.arg78gln p.arg59gln p.arg98gln p.arg98gln p.arg98gln p.met7leu p.met7leu p.met7leu

44 PARK7 PARK7 PON PON PON PON PON PON PON PON PON3 feature elongation frameshift ENST ENST ENST37749 *ENST ENST ENST ENST ENST ENST37749 ENST *ENST ENST ENST37749 ENST ENST ENST ENST *ENST22238 ENST *ENST22238 ENST *ENST22238 ENST *ENST22238 ENST *ENST22238 ENST *ENST22238 ENST *ENST22238 ENST *ENST ENST c.49a>c c.49a>c c.49a>c c.5a>g c.5a>g c.44a>g c.44a>g c.5a>g c.5a>g c.5a>g c.535g>a c.475g>a c.535g>a c.448g>a c.535g>a c.535g>a c.535g>a c.63t>a c.63t>a c.39dupg c.39dupg c.468a>g c.468a>g c.575a>g c.575a>g c.62c>t c.62c>t c.63g>a c.63g>a c.953c>t c.953c>t c.63c>t c.63c>t p.met7leu p.met7leu p.met7leu p.ala79thr p.ala59thr p.ala79thr p.ala5thr p.ala79thr p.ala79thr p.ala79thr p.leu55met p.leu55met p.val3glyf sx5 p.val3glyf sx p.gln92arg p.gln92arg p.ala2val p.ala2val p.thr38ile p.thr38ile

45 PON PON3 PON2 PON2 PON2 PON2 PON2 PON2 PON2 stop gained feature truncation frameshift ENST *ENST ENST ENST *ENST ENST4339 ENST53683 *ENST ENST4339 ENST53683 *ENST ENST53683 ENST4339 *ENST ENST4339 ENST53683 *ENST ENST4339 ENST53683 *ENST ENST53683 ENST4339 *ENST ENST4339 ENST53683 *ENST ENST *ENST ENST *ENST ENST c.63c>t c.94c>t c.94c>t c.94c>t c.286dela c.286dela c.349dela c.359t>g c.359t>g c.422t>g c.443c>g c.56c>g c.47c>g c.66t>g c.625t>g c.724t>g c.827c>t c.79c>t c.89c>t c.93c>t c.976c>t c.877c>t c.932c>g c.896c>g c.995c>g p.arg32x p.arg32x p.arg32x p.arg96glyfs X5 p.arg96glyfs X5 p.arg7glyf sx5 p.ile2arg p.ile2arg p.ile4arg p.ala48gly p.ala69gly p.ala36gly p.ser22ala p.ser29ala p.ser242ala p.ser276leu p.ser264leu p.ser297leu p.arg35cys p.arg326cys p.arg293cys p.ser3cys p.ser299cys p.ser332cys c.262a>g p.met88val PON c.262a>g p.met88val c.297g>a PON c.297g>a 2 6 c.48g>t p.met36ile PON c.48g>t p.met36ile PON3 *ENST c.69t>c

46 ENST c.69t>c PON3 *ENST c.89t>c PON3 *ENST c.954c>t PON3 *ENST c.97g>a p.gly324asp PRPH *ENST25786 c.83c>g ENST c.268c>g PRPH *ENST25786 c.4a>g ENST c.289a>g PRPH *ENST25786 c.7a>g ENST c.292a>g PRPH *ENST25786 c.225g>a p.val49met ENST c.4g>a p.val38met PRPH *ENST25786 c.23g>a p.val4ile ENST c.46g>a p.val4ile PRPH *ENST25786 c.33c>t p.arg435trp ENST c.488c>t p.arg64trp PRPH *ENST25786 c.26g>a p.arg9gln PRPH *ENST25786 c.322t>c p.phe8leu ENST4589 c.79t>c p.phe27leu PRPH *ENST25786 c.63c>t PRPH *ENST25786 c.829g>a p.ala277thr ENST c.4g>a p.ala6thr *ENST2244 c.77t>c ENST37269 c.77t>c ENST39322 c.77t>c *ENST2244 ENST37269 ENST39322 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST37269 ENST39322 c.655a>c c.655a>c c.655a>c c.75c>g c.75c>g c.75c>g c.869a>c c.869a>c c.869a>c p.gln552pro p.gln552pro p.gln552pro p.leu584val p.leu584val p.leu584val p.glu623asp p.glu623asp p.glu623asp *ENST2244 c.92a>g

47 ENST39322 ENST37269 *ENST2244 ENST39322 ENST37269 * ENST43644 ENST37269 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST39322 ENST37269 c.92a>g c.92a>g c.979c>g c.979c>g c.979c>g c.295c>t c.7369c>t c.234g>a c.234g>a c.234g>a c.24t>c c.24t>c c.24t>c c.2479a>g c.2479a>g c.2479a>g c.277c>t c.277c>t c.277c>t c.2755g>c c.2755g>c c.2755g>c c.2842c>a c.2842c>a c.2842c>a c.2964a>g c.2964a>g c.2964a>g c.2975a>g c.2975a>g c.2975a>g c.347c>t c.347c>t c.347c>t p.ala66gly p.ala66gly p.ala66gly p.leu699phe p.leu2457ph e p.leu84ser p.leu84ser p.leu84ser p.lys827glu p.lys827glu p.lys827glu p.ser96leu p.ser96leu p.ser96leu p.val99leu p.val99leu p.val99leu p.pro948thr p.pro948thr p.pro948thr p.lys992arg p.lys992arg p.lys992arg

48 feature elongation frameshift *ENST2244 ENST37269 ENST39322 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST37269 ENST39322 c.322a>g c.322a>g c.322a>g c.3229g>a c.3229g>a c.3229g>a c.3336t>c c.3336t>c c.3336t>c c.3455t>g c.3455t>g c.3455t>g c.3576t>g c.3576t>g c.3576t>g c.3754g>a c.3754g>a c.3754g>a c.393dup A c.393dup A c.393dup p.glu74gly p.glu74gly p.glu74gly p.asp77as n p.asp77as n p.asp77as n p.phe52cy s p.phe52cy s p.phe52cy s p.asp92glu p.asp92glu p.asp92glu p.gly252arg p.gly252arg p.gly252arg p.arg3thr fsx2 p.arg3thr fsx2 p.arg3thr

49 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST43644 ENST37269 ENST39322 *ENST2244 ENST37269 ENST39322 *ENST2244 ENST43644 ENST37269 ENST39322 A c.456a>g c.456a>g c.456a>g c.466t>g c.466t>g c.466t>g c.477t>c c.477t>c c.477t>c c.472t>g c.472t>g c.472t>g c.4755t>g c.4755t>g c.4755t>g c.56g>a c.56g>a c.56g>a c.527a>g c.527a>g c.527a>g c.5283a>g c.9a>g c.5283a>g c.5283a>g c.54a>g c.54a>g c.54a>g c.5563a>g c.289a>g c.5563a>g c.5563a>g fsx2 p.ile386val p.ile386val p.ile386val p.cys554gly p.cys554gly p.cys554gly p.leu58val p.leu58val p.leu58val p.arg69his p.arg69his p.arg69his p.thr855ala p.thr97ala p.thr855ala p.thr855ala

50 *ENST2244 ENST37269 ENST43644 ENST39322 *ENST2244 ENST37269 ENST39322 ENST43644 *ENST2244 ENST37269 ENST43644 ENST39322 *ENST2244 ENST39322 ENST37269 ENST43644 *ENST2244 ENST39322 ENST37269 *ENST2244 ENST39322 ENST37269 ENST43644 *ENST2244 ENST39322 ENST37269 ENST43644 c.5587a>g c.5587a>g c.33a>g c.5587a>g c.58t>c c.58t>c c.58t>c c.537t>c c.5842a>g c.5842a>g c.568a>g c.5842a>g c.5998c>g c.5998c>g c.5998c>g c.724c>g c.59g>a c.59g>a c.59g>a c.65g>a c.65g>a c.65g>a c.73g>a c.624t>c c.624t>c c.624t>c c.75t>c p.thr863ala p.thr863ala p.thr5ala p.thr863ala p.met948va l p.met948va l p.met9val p.met948va l p.gln2glu p.gln2glu p.gln2glu p.gln242glu p.arg2his p.arg2his p.arg2his p.arg22his p.arg22his p.arg22his p.arg244his *ENST2244 c.649a>g p.met27va

Names for ABO (ISBT 001) Blood Group Alleles

Names for ABO (ISBT 001) Blood Group Alleles Names for ABO (ISBT 001) blood group alleles v1.1 1102 Names for ABO (ISBT 001) Blood Group Alleles General description: The ABO system was discovered as in 1900 and is considered the first and clinically

More information

Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes

Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes Supplementary Information Jason Flannick*, Nicola L Beer*, Alexander G Bick,

More information

Names for H (ISBT 018) Blood Group Alleles

Names for H (ISBT 018) Blood Group Alleles Names for H (ISBT 018) Blood Group Alleles General description: The H blood group system consists of one antigen, H, that is carried on glycolipids and glycoproteins on the RBC membrane, where it is synthesised

More information

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes KM Kortüm 1,8 *, EK Mai 3,4 *, NH Hanafiah 3 *, CX Shi 1, YX Zhu 1, L Bruins 1, S Barrio 1,

More information

GALAFOLD (migalastat) capsules, for oral use Initial U.S. Approval: 2018

GALAFOLD (migalastat) capsules, for oral use Initial U.S. Approval: 2018 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GALAFOLD safely and effectively. See full prescribing information for GALAFOLD. GALAFOLD (migalastat)

More information

Supplementary material PCNT point mutations and familial intracranial aneurysms

Supplementary material PCNT point mutations and familial intracranial aneurysms Supplementary material PCNT point mutations and familial intracranial aneurysms Oswaldo Lorenzo-Betancor, MD, PhD 1, Patrick R. Blackburn, PhD 2,3, Emily Edwards, CCRP 4, Rocío Vázquez-do-Campo, MD 4,

More information

GALAFOLD (migalastat) capsules, for oral use Initial U.S. Approval: 2018

GALAFOLD (migalastat) capsules, for oral use Initial U.S. Approval: 2018 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GALAFOLD safely and effectively. See full prescribing information for GALAFOLD. GALAFOLD (migalastat)

More information

Hearing Loss Imaging Thyroid function tests TFT (age at test)

Hearing Loss Imaging Thyroid function tests TFT (age at test) Clinical Information on patients. Unclassified variants are denoted in brackets. EVA is enlarged vestibular aqueducts - Indicates no information. means asian. Patient TFT (age at test) 25215 c.1001+1g>a

More information

Colclough et al., Human Mutation 1

Colclough et al., Human Mutation 1 Region Colclough et al., Human Mutation 1 Supp. Table S1. List of HNF1A mutations Nucleotide Change NM_000545.5 Promoter and 5 UTR Mutations Protein Effect NM_000545.5 Three letter amino acid description

More information

LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene

LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene ACTA2* Exon 02-09 NM_001613.2 DSG2* Exon 01-15 NM_001943.3 ACTC1* Exon 01-06 NM_005159.4 DSP* Exon 01-24 NM_004415.2 APC* Exon 01-15

More information

analysis in hereditary breast/ovarian cancer families of Portuguese ancestry

analysis in hereditary breast/ovarian cancer families of Portuguese ancestry Clin Genet 2015: 88: 41 48 Printed in Singapore. All rights reserved Short Report 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12441 The role of targeted

More information

The InSiGHT Variant Interpretation Committee: the first ClinGen Expert Panel

The InSiGHT Variant Interpretation Committee: the first ClinGen Expert Panel ACGS, June 2018 The InSiGHT Variant Interpretation Committee: the first ClinGen Expert Panel Ian M. Frayling Member of Council & Variant Interpretation Committee (VIC) International Society for Gastrointestinal

More information

InheriGen Plus Disease Information

InheriGen Plus Disease Information DISEASE INFORMATION & MUTATIONS TESTED 17α-hydroxylase/17,20-lyase Deficiency CYP17A1 Brazilian 87% < 1 in 112 < 1 in 850 p.arg362cys, p.trp406arg, c.1243+5g>a, p.pro48fs, p.asp487_phe489del, p.tyr32x

More information

Genetic Testing and Analysis. (858) MRN: Specimen: Saliva Received: 07/26/2016 GENETIC ANALYSIS REPORT

Genetic Testing and Analysis. (858) MRN: Specimen: Saliva Received: 07/26/2016 GENETIC ANALYSIS REPORT GBinsight Sample Name: GB4411 Race: Gender: Female Reason for Testing: Type 2 diabetes, early onset MRN: 0123456789 Specimen: Saliva Received: 07/26/2016 Test ID: 113-1487118782-4 Test: Type 2 Diabetes

More information

ALANINE:GLYOXYLATE AMINOTRANSFERASE (AGXT) GENE (PRIMARY HYPEROXALURIA TYPE 1) MUTATION DATA BASE

ALANINE:GLYOXYLATE AMINOTRANSFERASE (AGXT) GENE (PRIMARY HYPEROXALURIA TYPE 1) MUTATION DATA BASE ALANINE:GLYOXYLATE AMINOTRANSFERASE (AGXT) GENE (PRIMARY HYPEROXALURIA TYPE 1) REFERENCE SEQUENCES: c.dna: NM_000030 g.dna: NG_008005.1 MUTATION DATA BASE Nomenclature: HGVS guidelines (http://www.hgvs.org/rec.html)

More information

CHAPTER IV RESULTS Microcephaly General description

CHAPTER IV RESULTS Microcephaly General description 47 CHAPTER IV RESULTS 4.1. Microcephaly 4.1.1. General description This study found that from a previous study of 527 individuals with MR, 48 (23 female and 25 male) unrelated individuals were identified

More information

Investigating the Patterns in SCN8A Mutations Linked to Early-Onset Seizures

Investigating the Patterns in SCN8A Mutations Linked to Early-Onset Seizures Investigating the Patterns in SCN8A Mutations Linked to Early-Onset Seizures Item Type text; Electronic Thesis Authors Chen, Debbie Publisher The University of Arizona. Rights Copyright is held by the

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION doi:10.1038/nature10833 Supplementary Table 1: Clinical information for 48 whole exome sequencing samples Sample ID Age Gender tumor location Death OS (months) Recurrence PFS

More information

Supplementary Table e1. Clinical and genetic data on the 37 participants from the WUSM

Supplementary Table e1. Clinical and genetic data on the 37 participants from the WUSM Supplementary Data Supplementary Table e1. Clinical and genetic data on the 37 participants from the WUSM cohort. Supplementary Table e2. Specificity, sensitivity and unadjusted ORs for glioma in participants

More information

Novel NPHS1 gene mutations in a Chinese family with congenital nephrotic syndrome

Novel NPHS1 gene mutations in a Chinese family with congenital nephrotic syndrome c Indian Academy of Sciences RESEARCH NOTE Novel NPHS1 gene mutations in a Chinese family with congenital nephrotic syndrome FENGJIE YANG, YAXIAN CHEN, YU ZHANG, LIRU QIU, YU CHEN and JIANHUA ZHOU Department

More information

Supplemental material Mutant DNMT3A: A Marker of Poor Prognosis in Acute Myeloid Leukemia Ana Flávia Tibúrcio Ribeiro, Marta Pratcorona, Claudia

Supplemental material Mutant DNMT3A: A Marker of Poor Prognosis in Acute Myeloid Leukemia Ana Flávia Tibúrcio Ribeiro, Marta Pratcorona, Claudia Supplemental material Mutant DNMT3A: A Marker of Poor Prognosis in Acute Myeloid Leukemia Ana Flávia Tibúrcio Ribeiro, Marta Pratcorona, Claudia Erpelinck-Verschueren, Veronika Rockova, Mathijs Sanders,

More information

De Leeneer et al., Human Mutation 1

De Leeneer et al., Human Mutation 1 De Leeneer et al., Human Mutation 1 Supp. Table S1A. Overview of the genes included in the workflow Ensembl Gene ID Ensembl Transcript ID Associated Gene Name ENSG00000198691 ENST00000370225 ABCA4 NM_000350.2

More information

Sample Test Report. Mayo Clinic GeneGuide. Report. Consumer Name DOB: 00/00/0000

Sample Test Report. Mayo Clinic GeneGuide. Report. Consumer Name DOB: 00/00/0000 Mayo Clinic GeneGuide Report Consumer Name DOB: // Table Of Contents Mayo Clinic GeneGuide Genetic Test Results Demographics and Ordering Information 3 How to Use This Report 4 Carrier Screening - No variants

More information

Molecular Diagnostic Testing by eyegene: Analysis of Patients With Hereditary Retinal Dystrophy Phenotypes Involving Central Vision Loss

Molecular Diagnostic Testing by eyegene: Analysis of Patients With Hereditary Retinal Dystrophy Phenotypes Involving Central Vision Loss Genetics Molecular Diagnostic Testing by eyegene: Analysis of Patients With Hereditary Retinal Dystrophy Phenotypes Involving Central Vision Loss Akhila Alapati, 1 Kerry Goetz, 2 John Suk, 1 Mili Navani,

More information

Supplementary Document

Supplementary Document Supplementary Document 1. Supplementary Table legends 2. Supplementary Figure legends 3. Supplementary Tables 4. Supplementary Figures 5. Supplementary References 1. Supplementary Table legends Suppl.

More information

ATM germline heterozygosity does not play a role in CLL initiation but influences rapid disease progression through loss of the remaining ATM allele

ATM germline heterozygosity does not play a role in CLL initiation but influences rapid disease progression through loss of the remaining ATM allele Published Ahead of Print on September 20, 2011, as doi:10.3324/haematol.2011.048827. Copyright 2011 Ferrata Storti Foundation. Early Release Paper ATM germline heterozygosity does not play a role in CLL

More information

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension Felix Beuschlein, Sheerazed Boulkroun, Andrea Osswald, Thomas Wieland, Hang N. Nielsen, Urs D. Lichtenauer,

More information

Intron p Hybrid with p.leu245val p. Gly336Cys. p.leu62phe p. Ala137Val p. Asn152Thr hybrid with p.leu245val p.

Intron p Hybrid with p.leu245val p. Gly336Cys. p.leu62phe p. Ala137Val p. Asn152Thr hybrid with p.leu245val p. RHD negative, i.e. null Phenotype Allele name Nucleotide change Exon Predicted amino acid change D RHD*01N.01 RHD deletion 1-10 p.0 Allele name detail Comments D RHD*08N.01 RHD*Pseudogene RHD* Ψ 37- bp

More information

Supplementary Table I. List of mutations presented by the Portuguese pediatric cohort with FH

Supplementary Table I. List of mutations presented by the Portuguese pediatric cohort with FH Supplementary Table I. List of mutations presented by the Portuguese pediatric cohort with FH Index patients (n=89) FH children Cascade screening (n=82) cdna Mutation Protein 3 0 c.10580g>a p.arg3527gln

More information

Genotype to phenotype correlations in cartilage oligomeric matrix protein associated chondrodysplasias

Genotype to phenotype correlations in cartilage oligomeric matrix protein associated chondrodysplasias (2014) 22, 1278 1282 & 2014 Macmillan Publishers Limited All rights reserved 1018-4813/14 www.nature.com/ejhg ARTICLE Genotype to phenotype correlations in cartilage oligomeric matrix protein associated

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Morfopoulou S, Brown JR, Davies EG, et al. Human coronavirus

More information

chr6: _ del HFE NM_ ,744 bp deletion Deletion of entire HFE gene 2

chr6: _ del HFE NM_ ,744 bp deletion Deletion of entire HFE gene 2 Table S1. Details of pathogenic and possibly pathogenic variants identified in the HH genes HFE, HFE2, HAMP, TFR2 and SLC40A1 from published reports. Variants have been classified as either 1, possibly

More information

Supplementary Materials for

Supplementary Materials for www.sciencemag.org/content/354/6319/aaf7000/suppl/dc1 Supplementary Materials for Genetic identification of familial hypercholesterolemia within a single U.S. health care system Noura S. Abul-Husn, Kandamurugu

More information

Supplementary Information. Exome sequencing of serous endometrial tumors identifies recurrent somatic

Supplementary Information. Exome sequencing of serous endometrial tumors identifies recurrent somatic Supplementary Information Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes Matthieu Le Gallo 1, Andrea J.

More information

Re-classification of variants: Implications from the cardiac perspective

Re-classification of variants: Implications from the cardiac perspective Re-classification of variants: Implications from the cardiac perspective Karen McGuire Oxford Medical Genetics Laboratories, Churchill Hospital, Old Road, Oxford, OX3 7LE. Re-classification New evidence

More information

Identifying Mutations Responsible for Rare Disorders Using New Technologies

Identifying Mutations Responsible for Rare Disorders Using New Technologies Identifying Mutations Responsible for Rare Disorders Using New Technologies Jacek Majewski, Department of Human Genetics, McGill University, Montreal, QC Canada Mendelian Diseases Clear mode of inheritance

More information

Nature Neuroscience: doi: /nn Supplementary Figure 1. Missense damaging predictions as a function of allele frequency

Nature Neuroscience: doi: /nn Supplementary Figure 1. Missense damaging predictions as a function of allele frequency Supplementary Figure 1 Missense damaging predictions as a function of allele frequency Percentage of missense variants classified as damaging by eight different classifiers and a classifier consisting

More information

J Clin Oncol 34: by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol 34: by American Society of Clinical Oncology INTRODUCTION VOLUME 34 NUMBER 34 DECEMBER 1, 2016 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the

More information

Supplementary Material Figure S1. RT-PCR validation and overall growth of pitpnm3, sars, and lemd3 morphants. Table S1. Cohort demographics.

Supplementary Material Figure S1. RT-PCR validation and overall growth of pitpnm3, sars, and lemd3 morphants. Table S1. Cohort demographics. Supplementary Material Figure S1. RT-PCR validation and overall growth of pitpnm3, sars, and lemd3 morphants. Table S1. Cohort demographics. Table S2. Gene symbols and data regarding potential oligogenic

More information

Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library

Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library Marilou Wijdicks International Product Manager Research For Life Science Research Only. Not for Use in Diagnostic Procedures.

More information

Research Article Identification of Novel ARSA Mutations in Chinese Patients with Metachromatic Leukodystrophy

Research Article Identification of Novel ARSA Mutations in Chinese Patients with Metachromatic Leukodystrophy International Journal of Genomics Volume 2018, Article ID 2361068, 9 pages https://doi.org/10.1155/2018/2361068 Research Article Identification of Novel ARSA Mutations in Chinese Patients with Metachromatic

More information

CIC Edizioni Internazionali

CIC Edizioni Internazionali Next generation sequencing in the identification of a rare genetic disease from preconceptional couple screening to preimplantation genetic diagnosis Claudio Dello Russo 1 Gianluca Di Giacomo 1 Alvaro

More information

Table e-1: Investigation of 33 patients with early onset epilepsy for KCNT1 mutations.

Table e-1: Investigation of 33 patients with early onset epilepsy for KCNT1 mutations. Table e1: Investigation of 33 patients with early onset epilepsy for KCNT1 mutations. Patient Phenotype Screening Method Diagnostic Karyotype Sanger sequencing NGS Diagnostic Panel WES chromosomal microarray

More information

s Unique autosomal recessive variant of palmoplantar keratoderma associated with hearing loss not caused by known mutations*

s Unique autosomal recessive variant of palmoplantar keratoderma associated with hearing loss not caused by known mutations* 154 Case Report s Unique autosomal recessive variant of palmoplantar keratoderma associated with hearing loss not caused by known mutations* Moustafa Abdelaal Hegazi 1,2 Sommen Manou 3 Hazem Sakr 4 Guy

More information

Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 german families suspected of hereditary nonpolyposis colorectal cancer

Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 german families suspected of hereditary nonpolyposis colorectal cancer Int. J. Cancer: 116, 692 702 (2005) ' 2005 Wiley-Liss, Inc. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 german families suspected of hereditary nonpolyposis colorectal cancer

More information

Germline Variation in Cancer-Susceptibility Genes in a Healthy, Ancestrally Diverse Cohort: Implications for Individual Genome Sequencing

Germline Variation in Cancer-Susceptibility Genes in a Healthy, Ancestrally Diverse Cohort: Implications for Individual Genome Sequencing Germline Variation in Cancer-Susceptibility Genes in a Healthy, Ancestrally Diverse Cohort: Implications for Individual Genome Sequencing Dale L. Bodian, Justine N. McCutcheon, Prachi Kothiyal, Kathi C.

More information

Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population

Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population ONCOLOGY REPORTS 36: 2823-2835, 2016 Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population Kristina Lagerstedt-Robinson 1, Anna Rohlin 2,3, Christos Aravidis 4, Beatrice Melin

More information

Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction

Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction He et al. BMC Medical Genetics (2018) 19:186 https://doi.org/10.1186/s12881-018-0693-7 RESEARCH ARTICLE Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney

More information

Phenylalanine hydroxylase deficiency in Mexico: genotype phenotype correlations, BH 4 responsiveness and evidence of a founder effect

Phenylalanine hydroxylase deficiency in Mexico: genotype phenotype correlations, BH 4 responsiveness and evidence of a founder effect Clin Genet 2015: 88: 62 67 Printed in Singapore. All rights reserved Short Report 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12444 Phenylalanine hydroxylase

More information

Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry

Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry Diabetologia (2017) 60:625 635 DOI 10.1007/s00125-016-4167-1 ARTICLE Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood

More information

Supplemental Data. De Novo Truncating Mutations in WASF1. Cause Intellectual Disability with Seizures

Supplemental Data. De Novo Truncating Mutations in WASF1. Cause Intellectual Disability with Seizures The American Journal of Human Genetics, Volume 13 Supplemental Data De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures Yoko Ito, Keren J. Carss, Sofia T. Duarte, Taila Hartley,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Mandelker D, Zhang L, Kemel Y, et al. Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based

More information

Downloaded from:

Downloaded from: Ryan, NS; Nicholas, JM; Weston, PS; Liang, Y; Lashley, T; Guerreiro, R; Adamson, G; Kenny, J; Beck, J; Chavez-Gutierrez, L; de Strooper, B; Revesz, T; Holton, J; Mead, S; Rossor, MN; Fox, NC (2016) Clinical

More information

*Correspondence and offprint requests to: Takashi Sekine; ORIGINAL ARTICLE ABSTRACT INTRODUCTION

*Correspondence and offprint requests to: Takashi Sekine;   ORIGINAL ARTICLE ABSTRACT INTRODUCTION Nephrol Dial Transplant (2014) 29: 376 384 doi: 10.1093/ndt/gft394 Advance Access publication 29 September 2013 Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: genetic

More information

p.arg119gly p.arg119his p.ala179thr c.540+1g>a c.617_633+6del Prediction basis structure

p.arg119gly p.arg119his p.ala179thr c.540+1g>a c.617_633+6del Prediction basis structure a Missense ATG p.arg119gly p.arg119his p.ala179thr p.ala189val p.gly206trp p.gly206arg p.arg251his p.ala257thr TGA 5 UTR 1 2 3 4 5 6 7 3 UTR Splice Site, Frameshift b Mutation p.gly206trp p.gly4fsx50 c.138+1g>a

More information

Concurrent Practical Session ACMG Classification

Concurrent Practical Session ACMG Classification Variant Effect Prediction Training Course 6-8 November 2017 Prague, Czech Republic Concurrent Practical Session ACMG Classification Andreas Laner / Anna Benet-Pagès 1 Content 1. Background... 3 2. Aim

More information

Multiplex target enrichment using DNA indexing for ultra-high throughput variant detection

Multiplex target enrichment using DNA indexing for ultra-high throughput variant detection Multiplex target enrichment using DNA indexing for ultra-high throughput variant detection Dr Elaine Kenny Neuropsychiatric Genetics Research Group Institute of Molecular Medicine Trinity College Dublin

More information

NGS in neurodegenerative disorders. Our first experience

NGS in neurodegenerative disorders. Our first experience NGS in neurodegenerative disorders Our first experience Milena Jankovic, PhD Laboratory for genetic and molecular diagnostic of neurological disorders Neurology Clinic, Clinical Center of Serbia University

More information

Table S2. Putative mutations identified in the CHH cohort

Table S2. Putative mutations identified in the CHH cohort Table S. Putative utations identified in the CHH cohort Sapl e Phenotyp e Gene nt change aa change Zyg SIF T PPH MaxEn t In vitro ExA C ExAC NFE Previous report ACMG classificatio n ACMG evidence codes

More information

Supplementary Information

Supplementary Information 1 Supplementary Information MATERIALS AND METHODS Study subjects Exome-sequenced HBOC patients Clinical characteristics of 24 exome-sequenced HBOC patients are presented in Table 1. Table 1. Clinical characteristics

More information

Genotype phenotype correlation in a cohort of Portuguese patients comprising the entire spectrum of VWD types: impact of NGS

Genotype phenotype correlation in a cohort of Portuguese patients comprising the entire spectrum of VWD types: impact of NGS Coagulation and Fibrinolysis 17 Genotype phenotype correlation in a cohort of Portuguese patients comprising the entire spectrum of VWD types: impact of NGS Teresa Fidalgo 1 ; Ramon Salvado 1 ; Irene Corrales

More information

Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry

Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry /, 2016, Vol. 7, (No. 49), pp: 80465-80481 Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at- for hereditary breast cancer and characterization of its genetic ancestry Gabriela C.

More information

Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Supplementary Material

Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Supplementary Material Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes Supplementary Material Johannes R. Lemke 1,2,*, Dennis Lal 2,3,4,5,*, Eva M. Reinthaler 2,6,*, Isabelle Steiner 7, Michael Nothnagel

More information

Home Brewed Personalized Genomics

Home Brewed Personalized Genomics Home Brewed Personalized Genomics The Quest for Meaningful Analysis Results of a 23andMe Exome Pilot Trio of Myself, Wife, and Son February 22, 2013 Gabe Rudy, Vice President of Product Development Exome

More information

Molecular Diagnostic Laboratory 18 Sequencing St, Gene Town, ZY Tel: Fax:

Molecular Diagnostic Laboratory 18 Sequencing St, Gene Town, ZY Tel: Fax: Molecular Diagnostic Laboratory 18 Sequencing St, Gene Town, ZY 01234 Tel: 555-920-3333 Fax: 555-920-3334 www.moldxlaboratory.com Patient Name: Jane Doe Specimen type: Blood, peripheral DOB: 04/05/1990

More information

Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS

Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS dr sc. Ana Krivokuća Laboratory for molecular genetics Institute for Oncology and

More information

doi: /brain/awp336 Brain 2010: 133;

doi: /brain/awp336 Brain 2010: 133; doi:10.1093/brain/awp336 Brain 2010: 133; 655 670 655 BRAIN A JOURNAL OF NEUROLOGY Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder Wilhelmina

More information

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Application Note Authors John McGuigan, Megan Manion,

More information

Reverse phenotyping: MCD Detection without clinical diagnosis. Diagnostic: NGS panels versus WES

Reverse phenotyping: MCD Detection without clinical diagnosis. Diagnostic: NGS panels versus WES Clinical Genetics Leading the way in genetic issues Reverse phenotyping: MCD Detection without clinical diagnosis Diagnostic: NGS panels versus WES Martina Wilke Laboratory Specialist Clinical Genetics

More information

EXOME SEQUENCING AS A SECOND-TIER DIAGNOSTIC APPROACH FOR CLINICALLY SUSPECTED DYSFERLINOPATHY PATIENTS

EXOME SEQUENCING AS A SECOND-TIER DIAGNOSTIC APPROACH FOR CLINICALLY SUSPECTED DYSFERLINOPATHY PATIENTS EXOME SEQUENCING AS A SECOND-TIER DIAGNOSTIC APPROACH FOR CLINICALLY SUSPECTED DYSFERLINOPATHY PATIENTS Marc Bartoli, Jean-Pierre Desvignes, Nicolas Lévy, Martin Krahn To cite this version: Marc Bartoli,

More information

Supplementary information

Supplementary information Supplementary information De novo mutations in HCN1 cause early infantile epileptic encephalopathy Caroline Nava 1 4,24, Carine Dalle 1,5,24, Agnès Rastetter 1, Pasquale Striano 6, Carolien G F de Kovel

More information

NIH Public Access Author Manuscript Nat Genet. Author manuscript; available in PMC 2012 June 18.

NIH Public Access Author Manuscript Nat Genet. Author manuscript; available in PMC 2012 June 18. NIH Public Access Author Manuscript Published in final edited form as: Nat Genet. ; 43(11): 1119 1126. doi:10.1038/ng.950. Exon capture analysis of G protein-coupled receptors identifies activating mutations

More information

Supplemental Data. Biallelic Variants in CNPY3, Encoding. an Endoplasmic Reticulum Chaperone, Cause Early-Onset Epileptic Encephalopathy

Supplemental Data. Biallelic Variants in CNPY3, Encoding. an Endoplasmic Reticulum Chaperone, Cause Early-Onset Epileptic Encephalopathy The American Journal of Human Genetics, Volume 102 Supplemental Data Biallelic Variants in CNPY3, Encoding an Endoplasmic Reticulum Chaperone, Cause Early-Onset Epileptic Encephalopathy Hiroki Mutoh, Mitsuhiro

More information

Combined study of ADAMTS13 and complement genes in the diagnosis of thrombotic microangiopathies using next-generation sequencing

Combined study of ADAMTS13 and complement genes in the diagnosis of thrombotic microangiopathies using next-generation sequencing eceived: 1 March 2017 Accepted: 15 May 2017 DOI: 10.1002/rth2.12016 OIGINAL ATICLE Combined study of ADAMTS13 and complement genes in the diagnosis of thrombotic microangiopathies using next-generation

More information

Alternative!allele!percentages!(AAP)!in!all!samples! tested!by!smmips.!

Alternative!allele!percentages!(AAP)!in!all!samples! tested!by!smmips.! Supplementary,Appendix,! Content, Title, Page,numbers, Supplementary!Figure!1! Cohorts!and!samples! 2! Supplementary!Figure!2! Levels!of!mosaicism!in!PIK3CA!in!the!study!cohort.! 3! Supplementary!Figure!3!

More information

Nature Structural & Molecular Biology: doi: /nsmb Supplementary Figure 1

Nature Structural & Molecular Biology: doi: /nsmb Supplementary Figure 1 Supplementary Figure 1 U1 inhibition causes a shift of RNA-seq reads from exons to introns. (a) Evidence for the high purity of 4-shU-labeled RNAs used for RNA-seq. HeLa cells transfected with control

More information

Supp. Materials and Methods

Supp. Materials and Methods Böhm et al., Human Mutation 1 Supp. Materials and Methods Patients Patient selection was based on the clinical presentation and/or histological findings suggesting centronuclear myopathy: muscle weakness

More information

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Gordon Blackshields Senior Bioinformatician Source BioScience 1 To Cancer Genetics Studies

More information

Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients

Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients Clin Genet 2016: 89: 336 340 Printed in Singapore. All rights reserved Short Report 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12620 Frequent incidence

More information

BWA alignment to reference transcriptome and genome. Convert transcriptome mappings back to genome space

BWA alignment to reference transcriptome and genome. Convert transcriptome mappings back to genome space Whole genome sequencing Whole exome sequencing BWA alignment to reference transcriptome and genome Convert transcriptome mappings back to genome space genomes Filter on MQ, distance, Cigar string Annotate

More information

Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity, through one

Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity, through one Page 1 of 26 Diabetes Care Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity, through one step PCR-based enrichment in combination with next-generation sequencing Amélie Bonnefond

More information

Variant interpretation exercise. ACGS Somatic Variant Interpretation Workshop Joanne Mason 21/09/18

Variant interpretation exercise. ACGS Somatic Variant Interpretation Workshop Joanne Mason 21/09/18 Variant interpretation exercise ACGS Somatic Variant Interpretation Workshop Joanne Mason 21/09/18 Format of exercise Compile a list of tricky variants across solid cancer and haematological malignancy.

More information

Supplementary Material

Supplementary Material Supplementary Material Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy Isabelle Perrault 1, Sylvain Hanein 1, Xavier Zanlonghi 2, Valérie Serre 1,

More information

Andrew Parrish, Richard Caswell, Garan Jones, Christopher M. Watson, Laura A. Crinnion 3,4, Sian Ellard 1,2

Andrew Parrish, Richard Caswell, Garan Jones, Christopher M. Watson, Laura A. Crinnion 3,4, Sian Ellard 1,2 METHOD ARTICLE An enhanced method for targeted next generation sequencing copy number variant detection using ExomeDepth [version 1; referees: 1 approved, 1 approved with reservations] 1 2 1 3,4 Andrew

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Sherman SI, Wirth LJ, Droz J-P, et al. Motesanib diphosphate

More information

Identification of genomic alterations in cervical cancer biopsies by exome sequencing

Identification of genomic alterations in cervical cancer biopsies by exome sequencing Chapter- 4 Identification of genomic alterations in cervical cancer biopsies by exome sequencing 105 4.1 INTRODUCTION Athough HPV has been identified as the prime etiological factor for cervical cancer,

More information

PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution

PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution Ghayda Mirzaa, 1,2 Andrew E. Timms, 3 Valerio Conti, 4 Evan August Boyle,

More information

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)

More information

Genetic characterization of antithrombin, protein C, and protein S deficiencies in Polish patients

Genetic characterization of antithrombin, protein C, and protein S deficiencies in Polish patients ORIGINAL ARTICLE Genetic characterization of antithrombin, protein C, and protein S deficiencies in Polish patients Ewa Wypasek 1,2, Javier Corral 3, Martine Alhenc Gelas 4, Wojciech Sydor 5, Teresa Iwaniec

More information

Reporting TP53 gene analysis results in CLL

Reporting TP53 gene analysis results in CLL Reporting TP53 gene analysis results in CLL Mutations in TP53 - From discovery to clinical practice in CLL Discovery Validation Clinical practice Variant diversity *Leroy at al, Cancer Research Review

More information

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology JULY 21, 2018 Genetics 101: SCN1A Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology Disclosures: I have no financial interests or relationships to disclose. Objectives 1. Review genetic

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Parkinson disease 8, automsomal dominant OMIM number for disease 607060 Disease

More information

Variant Classification. Author: Mike Thiesen, Golden Helix, Inc.

Variant Classification. Author: Mike Thiesen, Golden Helix, Inc. Variant Classification Author: Mike Thiesen, Golden Helix, Inc. Overview Sequencing pipelines are able to identify rare variants not found in catalogs such as dbsnp. As a result, variants in these datasets

More information

The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann Pick type C patients carrying missense mutations

The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann Pick type C patients carrying missense mutations The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann Pick type C patients carrying missense mutations Judit Macıas-Vidal 1,2,3, Marisa Giros 1,2,3, Martina Guerrero

More information

Introduction of an NGS gene panel into the Haemato-Oncology MPN service

Introduction of an NGS gene panel into the Haemato-Oncology MPN service Introduction of an NGS gene panel into the Haemato-Oncology MPN service Dr. Anna Skowronska, Dr Jane Bryon, Dr Samuel Clokie, Dr Yvonne Wallis and Professor Mike Griffiths West Midlands Regional Genetics

More information

Supplemental Table 1. The list of variants with their respective scores for each variant classifier Gene DNA Protein Align-GVGD Polyphen-2 CADD MAPP

Supplemental Table 1. The list of variants with their respective scores for each variant classifier Gene DNA Protein Align-GVGD Polyphen-2 CADD MAPP Supplemental Table 1. The list of variants with their respective scores for each variant classifier Gene DNA Protein Align-GVGD Polyphen-2 CADD MAPP Frequency Domain Mammals a 3 S/P b Mammals a 3 S/P b

More information

Targeted Next-Generation Sequencing to Diagnose Disorders of HDL Cholesterol

Targeted Next-Generation Sequencing to Diagnose Disorders of HDL Cholesterol Targeted Next-Generation Sequencing to Diagnose Disorders of HDL Cholesterol Singh N. Sadananda 1, Jia Nee Foo 2, Meng Tiak Toh 1, Lubomira Cermakova 3, Laia Trigueros- Motos 1, Teddy Chan 4, Herty Liany

More information

Analysis with SureCall 2.1

Analysis with SureCall 2.1 Analysis with SureCall 2.1 Danielle Fletcher Field Application Scientist July 2014 1 Stages of NGS Analysis Primary analysis, base calling Control Software FASTQ file reads + quality 2 Stages of NGS Analysis

More information

A complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis

A complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis APPLICATION NOTE Cell-Free DNA Isolation Kit A complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis Abstract Circulating cell-free DNA (cfdna) has been shown

More information